Profil
Bekim Osmani is the founder of Bottmedical AG (2019) and holds the title of Director.
Dr. Osmani is also the founder of Bottneuro AG.
Aktive Positionen von Bekim Osmani
| Unternehmen | Position | Beginn |
|---|---|---|
Bottmedical AG
 Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Gründer | 01.01.2019 |
Bottneuro AG
 Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Gründer | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
Bottmedical AG
Bottmedical AG Medical SpecialtiesHealth Technology Bottmedical AG is a Swiss company that produces CINNA & Naturaligner, which are the world's first antibacterial braces. The private company is based in Basel, Switzerland. These braces correct, protect, and retain teeth while continuously supporting oral hygiene. The company was founded in 2019 by Pascal Brenneisen, Tino Töpper, Jeannette von Jackowski, Bert Müller, Bekim Osmani, Guido Sigron, Tobias Hollritt. Tino Töpper has been the CEO since 2019. | Health Technology |
Bottneuro AG
Bottneuro AG Information Technology ServicesTechnology Services Bottneuro AG develops digital therapies for Alzheimer's disease by using electrical stimulation of glia cells in the brain. The company is based in Basel, Switzerland. The Swiss company was founded by Bekim Osmani, Alois C. Hopf, and Bekim Osmani has been the CEO since incorporation. | Technology Services |
